Personal information

Keywords

clinical pharmacology, Oncology, pharmacokinetics

Countries

Netherlands

Activities

Collapse all

Employment (4)

Centre for Human Drug Research: Leiden, South Holland, NL

2014-10 to present | Senior clinical scientist (clinical pharmacology)
Employment
Source: Self-asserted source
FE Stuurman

PRA Health Sciences Zuidlaren: Zuidlaren, Drenthe, NL

2014-01 to 2014-09 | Project manager (clinical pharmacology)
Employment
Source: Self-asserted source
FE Stuurman

Antoni van Leeuwenhoek Nederlands Kanker Instituut: Amsterdam, Noord-Holland, NL

2009-01 to 2013-09 | scientist (clincial pharmacology)
Employment
Source: Self-asserted source
FE Stuurman

Schering-Plough: Oss, NL

2007 to 2008 | Trainee Pharmacist
Employment
Source: Self-asserted source
FE Stuurman

Education and qualifications (4)

Utrecht University: Utrecht, Utrecht, NL

2009-01-01 to 2013-09-18 | PhD (Pharmacy)
Education
Source: Self-asserted source
FE Stuurman

Rijksuniversiteit Groningen: Groningen, Groningen, NL

2004 to 2006 | PharmD (Pharmacy)
Education
Source: Self-asserted source
FE Stuurman

Rijksuniversiteit Groningen: Groningen, Groningen, NL

1999 to 2006 | MSc (Pharmaceutical sciences)
Education
Source: Self-asserted source
FE Stuurman

Rijksuniversiteit Groningen: Groningen, Groningen, NL

1999 to 2005 | MSc (Pharmacy)
Education
Source: Self-asserted source
FE Stuurman

Works (14)

Repeatability and predictive value of lactate threshold concepts in endurance sports.

PloS one
2018-11 | Journal article
DOI: 10.1371/journal.pone.0206846
PMID: 30427900
Contributors: Heuberger JAAC; Gal P; Stuurman FE; de Muinck Keizer WAS; Mejia Miranda Y; Cohen AF
Source: Self-asserted source
FE Stuurman via Europe PubMed Central

A Novel Somatostatin-Dopamine Chimera (BIM23B065) Reduced Growth Hormone Secretion In A First-in-human Clinical Trial.

The Journal of clinical endocrinology and metabolism
2018-10 | Journal article
DOI: 10.1210/jc.2018-01364
PMID: 30371791
Contributors: de Boon WMI; van Esdonk MJ; Stuurman FE; Biermasz NR; Pons L; Paty I; Burggraaf J
Source: Self-asserted source
FE Stuurman via Europe PubMed Central

Enrichment of Circulating Endothelial Cells by CD34 Microbeads Followed by Enumeration Using Flow Cytometry.

Thrombosis and haemostasis
2017-12 | Journal article
DOI: 10.1160/th17-04-0254
PMID: 29212123
Contributors: Burylo AM; de Weger VA; Stuurman FE; Beijnen JH; Schellens JHM
Source: Self-asserted source
FE Stuurman via Europe PubMed Central

A dose-escalation study of bi-daily once weekly oral docetaxel either as ModraDoc001 or ModraDoc006 combined with ritonavir.

European journal of cancer (Oxford, England : 1990)
2017-11 | Journal article
DOI: 10.1016/j.ejca.2017.09.010
PMID: 29031170
Contributors: de Weger VA; Stuurman FE; Hendrikx JJMA; Moes JJ; Sawicki E; Huitema ADR; Nuijen B; Thijssen B; Rosing H; Keessen M et al.
Source: Self-asserted source
FE Stuurman via Europe PubMed Central

Erythropoietin on cycling performance - Authors' reply.

The Lancet. Haematology
2017-10 | Journal article
DOI: 10.1016/s2352-3026(17)30181-3
PMID: 28962681
Contributors: Heuberger JAAC; Rotmans JI; Gal P; Stuurman FE; Daniels JMA; de Kam ML; Cohen AF
Source: Self-asserted source
FE Stuurman via Europe PubMed Central

Effects of erythropoietin on cycling performance of well trained cyclists: a double-blind, randomised, placebo-controlled trial.

The Lancet. Haematology
2017-08 | Journal article
DOI: 10.1016/s2352-3026(17)30105-9
PMID: 28669689
Contributors: Heuberger JAAC; Rotmans JI; Gal P; Stuurman FE; van 't Westende J; Post TE; Daniels JMA; Moerland M; van Veldhoven PLJ; de Kam ML et al.
Source: Self-asserted source
FE Stuurman via Europe PubMed Central

Abstracts of the Dutch Society of Clinical Pharmacology and Biopharmacy meeting of March 26, 2013.

British journal of clinical pharmacology
2014-10 | Journal article
PMC: PMC4239970
Source: Self-asserted source
FE Stuurman via Europe PubMed Central

Cerebrovascular events during nilotinib treatment.

The Netherlands journal of medicine
2014-02 | Journal article
PMID: 24659599
Contributors: Jager NG; Stuurman FE; Baars JW; Opdam FL
Source: Self-asserted source
FE Stuurman via Europe PubMed Central

A phase 1 comparative pharmacokinetic and cardiac safety study of two intravenous formulations of CO-101 in patients with advanced solid tumors.

Journal of clinical pharmacology
2013-08 | Journal article
DOI: 10.1002/jcph.108
PMID: 23775853
Contributors: Stuurman FE; Lolkema MP; Huitema AD; Soetekouw PM; Rosing H; Rolfe L; Kaur P; Beijnen JH; van Tinteren H; Voest EE et al.
Source: Self-asserted source
FE Stuurman via Europe PubMed Central

Phase I study of oral CP-4126, a gemcitabine derivative, in patients with advanced solid tumors.

Investigational new drugs
2013-08 | Journal article
DOI: 10.1007/s10637-013-9925-z
PMID: 23345000
Contributors: Stuurman FE; Voest EE; Awada A; Witteveen PO; Bergeland T; Hals PA; Rasch W; Schellens JH; Hendlisz A
Source: Self-asserted source
FE Stuurman via Europe PubMed Central

Oral anticancer drugs: mechanisms of low bioavailability and strategies for improvement.

Clinical pharmacokinetics
2013-06 | Journal article
DOI: 10.1007/s40262-013-0040-2
PMID: 23420518
Contributors: Stuurman FE; Nuijen B; Beijnen JH; Schellens JH
Source: Self-asserted source
FE Stuurman via Europe PubMed Central

Pharmacokinetic evaluation of three oral formulations of docetaxel boosted with ritonavir: two single-drug formulations vs. a fixed-dose combination tablet.

Drug delivery and translational research
2013-06 | Journal article
DOI: 10.1007/s13346-012-0127-6
PMID: 25788133
Contributors: Moes JJ; Stuurman FE; Hendrikx JJ; Marchetti S; Huitema AD; Beijnen JH; Schellens JH; Nuijen B
Source: Self-asserted source
FE Stuurman via Europe PubMed Central

Pulsatile drug delivery to ileo-colonic segments by structured incorporation of disintegrants in pH-responsive polymer coatings.

Journal of controlled release : official journal of the Controlled Release Society
2008-12 | Journal article
DOI: 10.1016/j.jconrel.2008.08.008
PMID: 18775755
Contributors: Schellekens RC; Stellaard F; Mitrovic D; Stuurman FE; Kosterink JG; Frijlink HW
Source: Self-asserted source
FE Stuurman via Europe PubMed Central

A novel dissolution method relevant to intestinal release behaviour and its application in the evaluation of modified release mesalazine products.

European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences
2007-01 | Journal article
DOI: 10.1016/j.ejps.2006.09.004
PMID: 17085024
Contributors: Schellekens RC; Stuurman FE; van der Weert FH; Kosterink JG; Frijlink HW
Source: Self-asserted source
FE Stuurman via Europe PubMed Central
How many people are using ORCID?